Form FDA 1572

    In Regulatory & approvals

    Also known as: 1572, statement of investigator

    Form FDA 1572 is the statement an investigator signs for trials conducted under a US IND, committing to conduct the study according to the protocol and the applicable regulations. It lists the investigator, the site, the sub-investigators, the laboratories, and the reviewing IRB. Signing it creates a personal regulatory commitment, so it must be kept accurate and updated.

    Related terms


    Turn the vocabulary into a career

    The free CRLN Career Finder maps your background to a clinical-research role and builds a step-by-step roadmap. No cost, no card.

    Get your free roadmap →

    Educational reference only. Where regional rules differ, follow the regulation and the written procedures that apply where you work.

    We use optional analytics to improve CRLN.